Cardinal Health Q2 revenue $51.5B, non-GAAP EPS $1.32; raises FY23 guidance

CARDINAL HEALTH INC

2024-FY EPS reported -$0.30 revenue$101,072,000,000

Revenue $51.5B, up 13% YoY; GAAP operating loss $119M on $709M goodwill impairment in Medical segment.
Non-GAAP diluted EPS $1.32, up 4% YoY; non-GAAP operating earnings $467M, flat YoY.
Pharmaceutical segment profit $464M (+9%); Medical segment profit $17M (-66%).
FY23 non-GAAP EPS guidance raised to $5.20-$5.50 from $5.05-$5.40; pharma profit growth outlook raised to 4-6.5%.
Interest and other lowered to $115M-$130M from $140M-$160M.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

CARDINAL HEALTH INC reported results: revenue $51.5 billion, net income GAAP diluted loss per share was $0.50, EPS $1.32. Guidance raised.

Revenue: $51.5 billion
Net income: GAAP diluted loss per share was $0.50
EPS: $1.32
Guidance: raised
Result: reported results

Exact text from the filing

Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2023 revenues of $51.5 billion, an increase of 13% from the second quarter of fiscal year 2022. Second quarter GAAP operating loss was $119 million due to a non-cash, pre-tax goodwill impairment of $709 million related to the Medical segment. GAAP diluted loss per share was $0.50, primarily due to this impairment, net of tax effects. Second quarter non-GAAP operating earnings of $467 million were in-line with the second quarter of last year. Non-GAAP diluted earnings per share (EPS) increased 4% to $1.32, due to lower interest expense and a lower share count, partially offset by a higher non-GAAP effective tax rate.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

CARDINAL HEALTH INC filing history →

Source: SEC EDGAR

accession 0000721371-23-000005

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.